BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9507689)

  • 1. [Glucocorticosteroids in bronchial asthma. I. Mechanism of action and use in therapy].
    Kos-Kudła B; Ciesielska-Kopacz N; Marek B; Ostrowska Z; Zwirska-Korczala K; Nowak M; Buntner B
    Wiad Lek; 1997; 50(7-9):205-10. PubMed ID: 9507689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhaled glucocorticosteroids in treatment of bronchial asthma].
    Piotrowska B; Droszcz W
    Pol Merkur Lekarski; 1997 Feb; 2(8):126-8. PubMed ID: 9538658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticosteroids in bronchial asthma. II. Use of cortisol markers in various biological materials for evaluation of adrenocortical function].
    Kos-Kudła B; Ostrowska Z; Marek B; Kajdaniuk D; Ciesielska-Kopacz N; Buntner B
    Wiad Lek; 1997; 50(10-12):321-7. PubMed ID: 9557119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
    van der Velden VH
    Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticosteroid therapy in bronchial asthma with special reference to the prevention of life-threatening bronchial obstruction in high-risk asthma].
    Slapke J; Meister W; Schilling W; Hummel S; Förster R
    Z Erkr Atmungsorgane; 1987; 168(3):216-34. PubMed ID: 3314191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial asthma as neurogenic paroxysmal inflammatory disease: do some antiepileptic drugs have antiasthmatic properties?
    Lomia M
    Med Hypotheses; 2007; 69(4):858-9. PubMed ID: 17376599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of maintenance therapy in hospitalized patients with exacerbation of bronchial asthma: a six-year observation].
    Sereda VP; Svistov AS
    Klin Med (Mosk); 2005; 83(12):36-41. PubMed ID: 16502722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corticosteroids in the treatment of bronchial asthma].
    Schaanning CG
    Tidsskr Nor Laegeforen; 1973 Nov; 93(33):2411-4. PubMed ID: 4590878
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication?
    Sadowska AM; Klebe B; Germonpré P; De Backer WA
    Steroids; 2007 Jan; 72(1):1-6. PubMed ID: 17145070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of antibiotics in the treatment of bronchial asthma].
    Dziedziczko A
    Pol Merkur Lekarski; 2003 Jun; 14(84):653-7. PubMed ID: 14524294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-asthma drugs].
    Devillier P
    Rev Prat; 2001 Mar; 51(5):523-31. PubMed ID: 11345561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Using glucocorticosteroids during exacerbation of bronchial asthma].
    Rebrov AP; Karoli NA
    Ter Arkh; 2004; 76(3):83-9. PubMed ID: 15108469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic criteria of efficacy of inhalation glucocorticosteroids in non-severe bronchial asthma].
    Il'chenko VA; Kol'tsun SS; Terpigorev SA; Stotskaia TV; Slinchenko OI; Vasilenko IA; Loskutov VIu; Paleev NR
    Klin Med (Mosk); 2003; 81(1):32-6. PubMed ID: 12650093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Asthma therapy by the general practitioner--new approaches and progress. Why inhaled steroids and delayed action beta-2 adrenergic drugs should be combined early on].
    Petro W
    MMW Fortschr Med; 1999 Aug; 141(34):24-8. PubMed ID: 10726131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between inflammation and symptoms in asthma.
    Tillie-Leblond I; Montani D; Crestani B; de Blic J; Humbert M; Tunon-de-Lara M; Magnan A; Roche N; Ostinelli J; Chanez P
    Allergy; 2009 Mar; 64(3):354-67. PubMed ID: 19210358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
    Mortimer KJ; Tattersfield AE
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):523-39. PubMed ID: 16054541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positioning of glucocorticosteroids in asthma and allergic rhinitis guidelines (versus other therapies).
    Joos GF; Brusselle GG; Van Hoecke H; Van Cauwenberge P; Bousquet J; Pauwels RA
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):597-612, vii-viii. PubMed ID: 16054545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of treating patients with cortico-dependent bronchial asthma by means of endolymphatic and intrapulmonary administration of glucocorticosteroids].
    Nikitin AV; Omeliusik VV; Andreeva VV; Kanina RI
    Ter Arkh; 1989; 61(5):86-9. PubMed ID: 2781498
    [No Abstract]   [Full Text] [Related]  

  • 20. [Features of using glucocorticosteroids in treating bronchial asthma in older and elderly patients with erosive-ulcer lesions of the gastroduodenal zone].
    Asmolovskaia SV
    Eksp Klin Gastroenterol; 2002; (3):49-52, 120. PubMed ID: 12353390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.